Non-bacterial thrombotic endocarditis (NBTE) was frequently identified in early post-mortem
studies of patients with HIV infection, but has not been reported since 1989. The reason for …

In a study of 34 human immunodeficiency virus (HIV)-seropositive and 12 HIV-seronegative
intravenous drug users with 40 and 14 episodes, respectively, of infective endocarditis (IE) …

Background Cardiac complications are becoming more important in patients with HIV
infection. The most common is infective endocarditis (IE) in patients who are intravenous …

Background Immunosuppression caused by human immunodeficiency virus 1 (HIV)
infection appears to modify the clinical characteristics and to increase the severity of several …

Objectives: To determine the clinical features, sites of involvement, bacteriological findings,
and outcome of infective endocarditis (IE) in patients with HIV infection. Patients and …

Objective: The aim was to describe the echocardiographic features of patients with infective
endocarditis (IE), and to compare the manifestations of IE in HIV-positive versus HIV …

Abstract Background: Intravenous drug users (IDUs) are at increased risk of infective
endocarditis (IE). Patients and Methods: Episodes of IE in IDUs were retrospectively …

To determine the effect of human immunodeficiency virus (HIV) infection and other factors on
infective endocarditis (IE) among injection drug users (IDUs), the incidence of IE was …

Human immunodeficiency virus (HIV)-infected patients are at increased risk for serious and
recurrent bacterial infections. We hypothesized that the degree of immunosuppression may …

The risk of infectious complications in HIV patients has decreased with availability of highly
active antiretroviral therapy (HAART). Most of the studies done on infective endocarditis (IE) …